SLC1A2 and Huntington disease: CEF treatment upregulated the expression of cortical and striatal GLT1 level compared to saline treated group. This action is persisted even after GLT1 levels began to decrease when these mice are 13 weeks of age and overtly symptomatic.  Therefore, the cellular machinery underlying the CEF- upregulated GLT1 expression possibly working in late-stage HD.